Ref ID: 17751
Author:
Eunjung Kang, Hye Seung, Lee, Han Gyeol Kim, Hyun Kyung Kim, Seung-Kwan Lim, Young Hwa Choi.
Author address:
(Suwon, KR)
Full conference title:
22nd European Congress of Clinical Microbiology and Infectious Diseases
Abstract:
Objectives: Cryptococcosis is an opportunistic infection caused by two
species of the genus Cryptococcus neoformans and Cryptococcus gattii.
We previously reported the molecular epidemiological analysis of 78
clinical strains of the C. neoformans/C. gattii species complex, but
antifungal susceptibility test was not taken. The Purpose of this study is
to demonstrate the pattern of antifungal susceptibility of Cryptococcus
neoformans/C. gattii Complex of South Korea.
Methods: Strains The 78 strains were isolated from the clinical
specimens recovered from cryptococcosis patients who had been
hospitalized between 1999 and 2008 in seven medical centers in South
Korea.
Antifungal susceptibility 1 Microdilution test
Microdilution test was carried out according to the Clinical Laboratory
Standard Institute M27-A3 document. Amphotericin-B, voriconazole
and fluconazole were tested against all isolates twice. C. parapsilosis
ATCC 22019 was included as quality control.
2 VITEK-2 system
VITEK-2 system was performed according to the manufacturer’s
instructions.
Statistics: Statistical analysis was performed using the program SPSS
version 18.0 software, and p-value < 0.05 was used to define
significance. We compared the MIC of fluconazole in microdilution
test according to the time period divided by 1999-2000 and 2001-
2008. The Mann-Whitney test was used for comparison of MIC
according to the time period.
Results: Among 78 strains, 75 strains (96%) were C. neoformas
serotype A and three strains (4%) were C. gattii, serotype B. The
antifungal susceptibility test results shows in Table 1. There is no
resistant strain to amphotericin-B and voriconazole. Two strains are
susceptible dose dependent for fluconazole in broth microdilution test.
One strain in 73 strains appears to be resistant for flucytosine in
VITEK-2 system. Eleven strains were recovered in 1999 to 2000 and 67
strains were in 2001 to 2008. Geometric means were 5.84 and 4.54
respectively. The difference of MIC between the two time periods was
not statistically significant. (p = 0.698)
Abstract Number: P817
Conference Poster: y
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a